SCHEMBL12811766

SCHEMBL12811766

C/C=C(/C)c1ccc(-c2ccc3ncc(N4CCOCC4)nc3c2)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HPGD P15428 2/20 0.47
▸ PIK3CA P42336 3/20 0.46
▸ PIK3CD O00329 2/20 0.46
▸ PIK3CB P42338 2/20 0.46
▸ MTOR P42345 2/20 0.46
▸ PIK3CG P48736 2/20 0.46
▸ PRKDC P78527 1/20 0.46
▸ PIK3C3 Q8NEB9 1/20 0.46
▸ CDK6 Q00534 3/20 0.44
▸ PIM1 P11309 1/20 0.42
▸ LMNA P02545 1/20 0.41
▸ CYP3A4 P08684 1/20 0.41
▸ CYP2D6 P10635 1/20 0.41
▸ TSHR P16473 1/20 0.41
▸ MAPK1 P28482 1/20 0.41
▸ HSD17B10 Q99714 1/20 0.41
▸ CLK4 Q9HAZ1 1/20 0.41
▸ HTT P42858 1/20 0.40
▸ SMN1; SMN2 Q16637 1/20 0.40
▸ FGFR2 P21802 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12812029 0.88 PIK3CA (0.44) HPGDPIK3CAPIK3CDPIK3CBMTOR
SCHEMBL12812391 0.87 HPGD (0.53) HPGDPIK3CAPIK3CDPIK3CBMTOR
SCHEMBL3091537 0.85 PIK3CA (0.55) HPGDPIK3CAPIK3CDPIK3CBMTOR
SCHEMBL1442272 0.83 PIK3CA (0.50) HPGDPIK3CAPIK3CDPIK3CBMTOR
SCHEMBL1442616 0.83 PIK3CA (0.50) HPGDPIK3CAPIK3CDPIK3CBMTOR
SCHEMBL12812428 0.83 CDK6 (0.54) HPGDPIK3CAPIK3CDPIK3CBMTOR
SCHEMBL1444098 0.83 HPGD (0.53) HPGDPIK3CAPIK3CDPIK3CBMTOR
SCHEMBL1442506 0.82 CLK4 (0.61) HPGDPIK3CAPIK3CDPIK3CBMTOR
SCHEMBL1441974 0.82 MTOR (0.53) HPGDPIK3CAPIK3CDPIK3CBMTOR
SCHEMBL12812023 0.82 HPGD (0.62) HPGDPIK3CAPIK3CDPIK3CBMTOR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011026579-A1 SUBSTITUTED AMINOQUINOXALINES AS TYROSINE THREONINE KINASE INHIBITORS BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2011-03-10 — — WO disclosed
Send feedback